CAMAGÜEY. - The consolidation of its leading productions, and to add new making lines, become some of the main projections of work for this year of the Company Labiofam in this province.

With a wide scale destined for the pharmaceutical and biopharmaceutical market, which laboratory animals also include and offering environmental sanitation, the entity has been directing efforts to reach a more integral development, with the introduction of major expressions of the science and the technique.

One of the achievements during 2019 was the road towards better levels of efficiency and satisfaction of the markets; nevertheless, there were issues as the low deliveries of articles as the Ferrical, Nutrivin and the Hydrolyzed of proteins, this one of the highest demand for its extended use in the cattle.

Amado Maceda, the general manager, informed that the improvement and enlargement of the producing plant are among the things they are working, and he considered to be insufficient the amount of realized contracts, slightly more than 400 at present, and in it there are reservations where to direct the work of agents and healers.

Hanging subject, he said, is the assembly of the software of industrial maintenance, in addition to work towars the elevation of the plans, still below of others similar in the country, and reverse the current situation of more commercialized than producer.

The balances of 2019 show only fulfillments in the Nutrivin, Hemocan, Encima pepsin, Tar boric and camphorated alcohol, Viocan, and the Entire Talc, in addition to meat of bird, egg and milk, but distant they stayed of the goals, among others, in Propolina, Ferrical, Hydrolyzed of Proteins, Toxin, Plasma, Biorat, Borilab and Entire Humus.

2020 points towards the consolidation, even in the middle of serious economic circumstances, which demand a suitable and intelligent planning, and the ideal use of the available means.

Translated by Linet Acuña Quilez